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Cigarette smoking remains the leading cause of preventable death and disease in the 
United States. Despite known risks, 42.1 million Americans continue to smoke, making research 
into tobacco-related pathologies relevant and necessary.  We previously discovered that cigarette 
smoke exposure leads to tumor progression in the breast via platelet activating factor (PAF) and 
other phospholipase A₂ (PLA₂) metabolic pathways. These results led us to examine the PLA2 
metabolite, prostaglandin E₂ (PGE₂).  We observed the expression of PGE₂ in mouse bladder and 
human heart tissue from nonsmokers and long-term smokers via immunohistochemistry. The 
urothelium of mouse bladder revealed a significant increase in expression of PGE₂ when 
compared to the nonsmokers via immunohistochemical analysis. In addition, we examined PGE₂ 
expression in cardiac biopsy patients and found no significant increase in expression. Our results 
suggest that while cigarette smoking may play a role in cancer of the breast and bladder, it may 
not have significant consequences in other pathologies such as heart disease. Our future studies 
aim at investigating other members of the PLA2 family in bladder for similarities to 
tumorigenesis and progression in the breast.  Overall, we have concluded for the first time that 
cigarette smoke exposure increases PGE₂ expression in the bladder following exposure. This 
provides a potential therapeutic target for cigarette smoked-induced tumorigenesis and 
progression. 
